INNOVATION | FOOD TECHNOLOGY

As GLP-1 medicines reshape appetite and eating patterns, food innovation is moving beyond the simple pursuit of fewer calories. Protein and fiber are emerging as two of the most important components of a new product-development equation: delivering more nutrition in less food.

Key Takeaways

• Protein and fiber are converging into the same formulation conversation, rather than being treated as separate consumer needs.
• Adding protein alone is no longer enough. Products need to deliver meaningful nutrition in smaller volumes without sacrificing taste or texture.
• Fiber is moving from a supporting role to a co-star, helping offset GI side effects of GLP-1 use while boosting nutrient density.
• The bigger opportunity isn’t a niche “GLP-1 friendly” category. It’s nutritionally efficient food that appeals to a much broader market.
• Trade-offs remain real: higher protein and fiber levels raise ingredient costs and formulation complexity, and consumers may resist products that feel overly medicalized.

For years, high-protein foods and fiber-rich products largely occupied different corners of the health market. In 2026, those strategies are increasingly converging.

The catalyst is bigger than GLP-1 medications alone. Consumers are already showing greater interest in protein, digestive health, satiety and nutrient density. But appetite-suppressing medicines are accelerating the need to rethink what a meal or snack should deliver when consumers may be eating substantially less.

Protein Has a New Job

Protein’s popularity predates the GLP-1 boom, but its role is evolving.

A 2025 joint advisory from the American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association and The Obesity Society identified maintaining adequate nutrition and preserving lean mass as important considerations during GLP-1 therapy. The advisory notes that reduced appetite can make adequate protein intake more difficult, and emphasizes nutrient-dense protein sources alongside resistance training.

For food manufacturers, that creates an innovation challenge. Adding protein is no longer enough. Products increasingly need to deliver meaningful protein in smaller volumes without excessive calories, poor texture or an undesirable eating experience.

Industry activity already reflects this shift. Reuters reported in August that ice cream manufacturers are responding to changing health expectations and GLP-1 adoption with strategies including smaller portions and higher-protein formulations. Nestlé is also developing products aimed at consumers using weight-loss medicines, with protein among the nutritional priorities.

Fiber Moves From Supporting Role to Co-Star

Protein may attract more attention, but fiber could become equally important.

GLP-1 medicines can be associated with gastrointestinal effects, including constipation. Fiber contributes to digestive health and can increase the nutritional value of foods designed for consumers eating smaller quantities, which is pushing protein and fiber into the same formulation conversation.

At IFT FIRST 2026, one notable innovation trend was precisely that combination, with product developers looking at nutrient density, satiety, digestive health and muscle maintenance together rather than as separate consumer needs. NielsenIQ similarly identified protein and fiber as prominent themes at Expo West 2026, with protein moving into snacks, beverages and pantry products while fiber appeared increasingly in beverages, snacks and baked foods.

The Opportunity Is Bigger Than “GLP-1 Friendly”

The temptation for brands will be to create a dedicated category of products carrying GLP-1-oriented positioning. That opportunity exists, but it may be too narrow.

The larger market could be foods designed around nutritional efficiency: smaller, satisfying portions that deliver protein, fiber and other essential nutrients without sacrificing taste. That proposition can appeal not only to people taking GLP-1 medicines, but also to consumers interested in healthy aging, weight management, metabolic health and convenient nutrition.

There are trade-offs. Higher protein and fiber levels can increase ingredient costs and create formulation challenges involving texture, flavor, viscosity and digestive tolerance. Consumers may also resist products that appear overly medicalized.

Global Food Intelligence Perspective

The GLP-1 era may ultimately change one of food manufacturing’s oldest assumptions: that greater consumption drives greater value.

If consumers increasingly eat less, the competitive question becomes what manufacturers can deliver within every calorie, bite and portion. Protein and fiber are therefore more than two fashionable nutrients. Together, they point toward a broader innovation model where nutrient density, portion design, sensory quality and convenience converge.

The winners may not be companies selling consumers more food. They may be those making less food deliver more.

---

Sources

1. Mozaffarian, D. et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory. Obesity, 2025.
2. The Food Institute. 3 Key Trends on Display at IFT FIRST 2026. July 20, 2026.
3. NielsenIQ. Expo West 2026: Key Trends in Food, Beverage & Wellness. 2026.
4. Reuters. Ice cream makers bet consumers still want treats, just healthier ones. August 13, 2026.
5. Reuters. Nestlé looks to develop new products to serve users of weight-loss drugs. August 17, 2026.